Fakhrieh S Vojdani

Title: **Innovative Contributions of Fakhrieh S Vojdani**

Introduction

Fakhrieh S Vojdani, located in Davis, California, is an accomplished inventor with a portfolio of four patents. His work has significantly contributed to the field of biotechnology, particularly in the development of novel hybrid interferons and improved viral vector systems.

Latest Patents

Among his latest patents is the groundbreaking work on the selection and characterization of novel plant-derived recombinant human interferons with broad-spectrum activity. This invention describes methods to derive hybrid type 1 interferons that have shown effectiveness against highly pathogenic viruses of biodefense significance. The process involved creating libraries of hybrid interferon genes through gene shuffling, followed by the expression and screening of proteins for activity against targeted viruses.

Additionally, Vojdani has developed a patent focusing on viral coat protein variants with self-subtracting properties. This invention centers on a modified viral vector that features a coat protein altered by the addition of a cysteine residue. This modification leads to lower solubility of the virus, facilitating the purification of recombinant proteins expressed from the modified viral vector. The patent also outlines methods for reducing viral coat protein impurities during purification and biocontainment techniques for recombinant viral vectors.

Career Highlights

Throughout his career, Fakhrieh S Vojdani has held significant positions in companies such as Large Scale Biology Corporation, where he applied his innovative expertise to advance biotechnological applications. His patents showcase his commitment to addressing critical challenges in the field.

Collaborations

Vojdani has collaborated with prominent colleagues, including Hal S Padgett and Andrew A Vaewhongs. These partnerships have further enriched his research and innovation in biotechnological developments.

Conclusion

Fakhrieh S Vojdani stands out as a pioneering inventor in the biotechnology sector, contributing valuable patents that enhance our understanding of viral interactions and therapeutic possibilities. His innovative approaches aim to improve public health and safety through advanced biotechnological methods.